Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia

MPT Lunn, RAC Hughes… - Cochrane database of …, 2014 - cochranelibrary.com
Background Duloxetine is a balanced serotonin and noradrenaline reuptake inhibitor
licensed for the treatment of major depressive disorders, urinary stress incontinence and the …

Dysfunctional endogenous analgesia during exercise in patients with chronic pain: to exercise or not to exercise?

J Nijs, E Kosek, J Van Oosterwijck… - Pain physician, 2012 - repository.uantwerpen.be
Background: Exercise is an effective treatment for various chronic pain disorders, including
fibromyalgia, chronic neck pain, osteoarthritis, rheumatoid arthritis, and chronic low back …

[HTML][HTML] The role of the central nervous system in the generation and maintenance of chronic pain in rheumatoid arthritis, osteoarthritis and fibromyalgia

YC Lee, NJ Nassikas, DJ Clauw - Arthritis research & therapy, 2011 - Springer
Pain is a key component of most rheumatologic diseases. In fibromyalgia, the importance of
central nervous system pain mechanisms (for example, loss of descending analgesic activity …

EULAR evidence-based recommendations for the management of fibromyalgia syndrome

SF Carville, S Arendt-Nielsen, H Bliddal… - Annals of the …, 2008 - ard.bmj.com
Objective: To develop evidence-based recommendations for the management of
fibromyalgia syndrome. Methods: A multidisciplinary task force was formed representing 11 …

Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia

P Welsch, N Üçeyler, P Klose, B Walitt… - Cochrane Database …, 2018 - cochranelibrary.com
Background Fibromyalgia is a clinically defined chronic condition of unknown etiology
characterized by chronic widespread pain that often co‐exists with sleep disturbances …

Management of fibromyalgia syndrome

DL Goldenberg, C Burckhardt, L Crofford - Jama, 2004 - jamanetwork.com
ContextThe optimal management of fibromyalgia syndrome (FMS) is unclear and
comprehensive evidence-based guidelines have not been reported. ObjectiveTo provide up …

[PDF][PDF] The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses

R Bennett - Clinical and experimental rheumatology, 2005 - atriumhealth.org
ABSTRACT The Fibromyalgia Impact Questionnaire (FIQ) was developed in the late 1980s
by clinicians at Oregon Health & Science University in an attempt to capture the total …

Acceptance and commitment therapy for fibromyalgia: a randomized controlled trial

RK Wicksell, M Kemani, K Jensen… - … journal of pain, 2013 - Wiley Online Library
Background Fibromyalgia (FM) is characterized by widespread pain and co‐morbid
symptoms such as fatigue and depression. For FM, medical treatments alone appear …

Fibromyalgia: an overview

DJ Clauw - The American journal of medicine, 2009 - Elsevier
Fibromyalgia is the diagnosis given to individuals with chronic widespread musculoskeletal
pain for which no alternative cause, such as tissue inflammation or damage, can be …

Comparison of amitriptyline and us food and drug administration–approved treatments for fibromyalgia: a systematic review and network meta-analysis

HM Farag, I Yunusa, H Goswami, I Sultan… - JAMA Network …, 2022 - jamanetwork.com
Importance Amitriptyline is an established medication used off-label for the treatment of
fibromyalgia, but pregabalin, duloxetine, and milnacipran are the only pharmacological …